Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Choice impulsivity: Definitions, measurement issues, and clinical implications

  • Kristen R. Hamilton
  • , Marci R. Mitchell
  • , Victoria C. Wing
  • , Iris M. Balodis
  • , Warren K. Bickel
  • , Mark Fillmore
  • , Scott D. Lane
  • , C. W. Lejuez
  • , Andrew K. Littlefield
  • , Maartje Luijten
  • , Charles W. Mathias
  • , Suzanne H. Mitchell
  • , T. Celeste Napier
  • , Brady Reynolds
  • , Christian G. Schütz
  • , Barry Setlow
  • , Kenneth J. Sher
  • , Alan C. Swann
  • , Stephanie E. Tedford
  • , Melanie J. White
  • Catharine A. Winstanley, Richard Yi, Marc N. Potenza, F. Gerard Moeller

Producción científica: Articlerevisión exhaustiva

232 Citas (Scopus)

Resumen

Impulsivity critically relates to many psychiatric disorders. Given the multifaceted construct that impulsivity represents, defining core aspects of impulsivity is vital for the assessment and understanding of clinical conditions. Choice impulsivity (CI), involving the preferential selection of smaller sooner rewards over larger later rewards, represents one important type of impulsivity. The International Society for Research on Impulsivity (InSRI) convened to discuss the definition and assessment of CI and provide recommendations regarding measurement across species. Commonly used preclinical and clinical CI behavioral tasks are described, and considerations for each task are provided to guide CI task selection. Differences in assessment of CI (self-report, behavioral) and calculating CI indices (e.g., area-under-the-curve, indifference point, and steepness of discounting curve) are discussed along with properties of specific behavioral tasks used in preclinical and clinical settings. The InSRI group recommends inclusion of measures of CI in human studies examining impulsivity. Animal studies examining impulsivity should also include assessments of CI and these measures should be harmonized in accordance with human studies of the disorders being modeled in the preclinical investigations. The choice of specific CI measures to be included should be based on the goals of the study and existing preclinical and clinical literature using established CI measures.

Idioma originalEnglish
Páginas (desde-hasta)182-198
Número de páginas17
PublicaciónPersonality Disorders: Theory, Research, and Treatment
Volumen6
N.º2
DOI
EstadoPublished - abr 1 2015

Nota bibliográfica

Publisher Copyright:
© 2015 American Psychological Association.

Financiación

FinanciadoresNúmero del financiador
National Institute on Drug AbuseP20DA027844
National Institute on Drug Abuse

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Clinical Psychology
    • Psychiatry and Mental health

    Huella

    Profundice en los temas de investigación de 'Choice impulsivity: Definitions, measurement issues, and clinical implications'. En conjunto forman una huella única.

    Citar esto